Literature DB >> 11056098

Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans.

A Q Galvan1, F Galetta, A Natali, E Muscelli, A M Sironi, G Cini, S Camastra, E Ferrannini.   

Abstract

BACKGROUND: Hyperinsulinemia and insulin resistance may contribute to the development of cardiac hypertrophy. In humans, however, the evidence is inconclusive. METHODS AND
RESULTS: We studied 50 nondiabetic subjects covering a wide range of age (20 to 65 years), body mass index (BMI, 19 to 40 kg x m(-2)), and mean blood pressure (72 to 132 mm Hg). Plasma insulin concentrations and secretory rates were measured at baseline and during an oral glucose tolerance test; insulin sensitivity was measured by the insulin clamp technique. Left ventricular mass (LVM) (by 2D M-mode echocardiography) was distributed normally and was higher in obese (BMI >/=27 kg x m(-2), n=16) or hypertensive patients (blood pressure >140/90 mm Hg, n=21) (50+/-8 and 55+/-10 g x m(-2.7), respectively) than in 13 nonobese, normotensive subjects (40+/-8 g x m(-2.7), P:=0.0004). In a multivariate model adjusting for sex, age, BMI, and blood pressure, neither insulin concentrations (fasting or postglucose) nor insulin sensitivity or secretory rates were significant correlates of LVM. Systolic blood pressure (P:=0.003) and BMI (P:=0.01) were the only independent correlates of LVM. From the regression, the impact of hypertension (as a systolic pressure of 180 versus 140 mm Hg=+20%) was twice as large as that of obesity (as a BMI of 35 versus 25 kg x m(-2)=+11%), the two factors being additive.
CONCLUSIONS: When adequate account is taken of body mass and blood pressure, insulin, as concentration, secretion, or action, is not an independent determinant of LVM in nondiabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056098     DOI: 10.1161/01.cir.102.18.2233

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Making sense of subclinical cardiac alterations in patients with diabetes.

Authors:  Manan Pareek; Michael Hecht Olsen
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

Review 2.  Diabetes and the risk of heart failure.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Heart Fail Clin       Date:  2011-10-13       Impact factor: 3.179

3.  Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael L Chuang; Carol J Salton; Caroline S Fox; Susan J Blease; Susan B Yeon; Warren J Manning; Christopher J O'Donnell
Journal:  Circ Cardiovasc Imaging       Date:  2010-03-05       Impact factor: 7.792

4.  Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors.

Authors:  Maya Peer; Mona Boaz; Matas Zipora; Marina Shargorodsky
Journal:  Int J Angiol       Date:  2013-12

5.  ACE gene polymorphism and cardiac structure in patients with insulin resistance.

Authors:  Fulya Akin; Sebahat Turgut; Dursun Dursunoglu; Gunfer Turgut; Ugur Karasu; Sukru Gur
Journal:  Mol Biol Rep       Date:  2008-03-18       Impact factor: 2.316

6.  Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population.

Authors:  Kazuo Eguchi; Bernadette Boden-Albala; Zhezhen Jin; Tatjana Rundek; Ralph L Sacco; Shunichi Homma; Marco R Di Tullio
Journal:  Am J Cardiol       Date:  2008-04-11       Impact factor: 2.778

7.  The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals.

Authors:  Gaia Chiara Mannino; Carolina Averta; Teresa Vanessa Fiorentino; Elena Succurro; Rosangela Spiga; Elettra Mancuso; Sofia Miceli; Maria Perticone; Angela Sciacqua; Francesco Andreozzi; Giorgio Sesti
Journal:  Cardiovasc Diabetol       Date:  2021-05-29       Impact factor: 9.951

Review 8.  The metabolic syndrome and its relationship to hypertensive target organ damage.

Authors:  Giuseppe Mulè; Giovanni Cerasola
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

Review 9.  Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity.

Authors:  Mohamed Asrih; François Mach; Alessandra Quercioli; Franco Dallegri; Fabrizio Montecucco
Journal:  Mediators Inflamm       Date:  2013-04-10       Impact factor: 4.711

10.  Association of Gestational Diabetes Mellitus With Left Ventricular Structure and Function: The CARDIA Study.

Authors:  Duke Appiah; Pamela J Schreiner; Erica P Gunderson; Suma H Konety; David R Jacobs; Chike C Nwabuo; Imo A Ebong; Hilary K Whitham; David C Goff; Joao A Lima; Ivy A Ku; Samuel S Gidding
Journal:  Diabetes Care       Date:  2016-01-06       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.